{
     "PMID": "26973100",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161213",
     "LR": "20161230",
     "IS": "1558-1497 (Electronic) 0197-4580 (Linking)",
     "VI": "40",
     "DP": "2016 Apr",
     "TI": "Differential effects of amyloid-beta 1-40 and 1-42 fibrils on 5-HT1A serotonin receptors in rat brain.",
     "PG": "11-21",
     "LID": "10.1016/j.neurobiolaging.2015.12.008 [doi] S0197-4580(15)00612-0 [pii]",
     "AB": "Evidence accumulates suggesting a complex interplay between neurodegenerative processes and serotonergic neurotransmission. We have previously reported an overexpression of serotonin 5-HT1A receptors (5-HT(1A)R) after intrahippocampal injections of amyloid-beta 1-40 (Abeta40) fibrils in rats. This serotonergic reactivity paralleled results from clinical positron emission tomography studies with [(18)F]MPPF revealing an overexpression of 5-HT(1A)R in the hippocampus of patients with mild cognitive impairment. Because Abeta40 and Abeta42 isoforms are found in amyloid plaques, we tested in this study the hypothesis of a peptide- and region-specific 5-HT(1A)R reactivity by injecting them, separately, into the hippocampus or striatum of rats. [(18)F]MPPF in vitro autoradiography revealed that Abeta40 fibrils, but not Abeta42, were triggering an overexpression of 5-HT(1A)R in the hippocampus and striatum of rat brains after 7 days. Immunohistochemical approaches targeting neuronal precursor cells, mature neurons, and astrocytes showed that Abeta42 fibrils caused more pathophysiological damages than Abeta40 fibrils. The mechanisms of Abeta40 fibrils-induced 5-HT(1A)R expression remains unknown, but hypotheses including neurogenesis, glial expression, and axonal sprouting are discussed.",
     "CI": [
          "Copyright (c) 2016 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Verdurand, Mathieu",
          "Chauveau, Fabien",
          "Daoust, Alexia",
          "Morel, Anne-Laure",
          "Bonnefoi, Frederic",
          "Liger, Francois",
          "Berod, Anne",
          "Zimmer, Luc"
     ],
     "AU": [
          "Verdurand M",
          "Chauveau F",
          "Daoust A",
          "Morel AL",
          "Bonnefoi F",
          "Liger F",
          "Berod A",
          "Zimmer L"
     ],
     "AD": "Universite de Lyon; Lyon Neuroscience Research Center, CNRS UMR5292; INSERM U1028, Universite Claude Bernard Lyon 1, Lyon, France. Electronic address: verdurand@cermep.fr. Universite de Lyon; Lyon Neuroscience Research Center, CNRS UMR5292; INSERM U1028, Universite Claude Bernard Lyon 1, Lyon, France. Universite de Lyon; Lyon Neuroscience Research Center, CNRS UMR5292; INSERM U1028, Universite Claude Bernard Lyon 1, Lyon, France. Universite de Lyon; Lyon Neuroscience Research Center, CNRS UMR5292; INSERM U1028, Universite Claude Bernard Lyon 1, Lyon, France. CERMEP-Imaging Platform, Lyon, France. CERMEP-Imaging Platform, Lyon, France. Universite de Lyon; Lyon Neuroscience Research Center, CNRS UMR5292; INSERM U1028, Universite Claude Bernard Lyon 1, Lyon, France. Universite de Lyon; Lyon Neuroscience Research Center, CNRS UMR5292; INSERM U1028, Universite Claude Bernard Lyon 1, Lyon, France; CERMEP-Imaging Platform, Lyon, France; Hospices Civils de Lyon, Lyon, France. Electronic address: zimmer@univ-lyon1.fr.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151219",
     "PL": "United States",
     "TA": "Neurobiol Aging",
     "JT": "Neurobiology of aging",
     "JID": "8100437",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Peptide Fragments)",
          "0 (Receptors, Serotonin, 5-HT1)",
          "0 (amyloid beta-protein (1-40))",
          "0 (amyloid beta-protein (1-42))"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*diagnostic imaging/*metabolism",
          "Amyloid beta-Peptides/*administration & dosage",
          "Animals",
          "Cognitive Dysfunction/metabolism",
          "Corpus Striatum/diagnostic imaging/*metabolism",
          "Disease Models, Animal",
          "Hippocampus/diagnostic imaging/*metabolism",
          "Immunohistochemistry",
          "Injections",
          "Male",
          "Peptide Fragments/*administration & dosage",
          "Plaque, Amyloid/metabolism",
          "Positron-Emission Tomography",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, Serotonin, 5-HT1/*metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "5-HT1A receptors",
          "Alzheimer's disease",
          "Amyloid-beta peptides",
          "Positron emission tomography",
          "Serotonin"
     ],
     "EDAT": "2016/03/15 06:00",
     "MHDA": "2016/12/15 06:00",
     "CRDT": [
          "2016/03/15 06:00"
     ],
     "PHST": [
          "2015/03/19 00:00 [received]",
          "2015/12/08 00:00 [revised]",
          "2015/12/15 00:00 [accepted]",
          "2016/03/15 06:00 [entrez]",
          "2016/03/15 06:00 [pubmed]",
          "2016/12/15 06:00 [medline]"
     ],
     "AID": [
          "S0197-4580(15)00612-0 [pii]",
          "10.1016/j.neurobiolaging.2015.12.008 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neurobiol Aging. 2016 Apr;40:11-21. doi: 10.1016/j.neurobiolaging.2015.12.008. Epub 2015 Dec 19.",
     "term": "hippocampus"
}